Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSMP.L Regulatory News (SMP)

  • There is currently no data for SMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - ST MODWEN PROPERTIES PLC

5 Aug 2021 12:08

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)Full name of discloser:Barclays PLC.
 
(b)Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c)Name of offeror/offeree in relation to whoseST MODWEN PROPERTIES PLC
relevant securities this form relates:
(d)If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e)Date position held/dealing undertaken:

04 August 2021

(f)In addition to the company in 1(c) above, is the discloser makingNO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

10p ordinary

 

 

Interests

Short Positions

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

and/or controlled:

10,172,271

4.57%

45,023

0.02%

 

 

 

 

(2)

Cash-settled derivatives:

 

 

 

 

9,397

0.00%

8,581,110

3.85%

 

 

 

 

(3)

Stock-settled derivatives (including options)

 

 

 

 

and agreements to purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

TOTAL:

10,181,668

4.57%

8,626,133

3.87%

 

 

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevantPurchase/sale

Number of

Price per unit
security

securities

10p ordinaryPurchase

786

5.5882 GBP
10p ordinaryPurchase

1,703

5.5950 GBP
10p ordinaryPurchase

88,100

5.5911 GBP
10p ordinaryPurchase

376,075

5.5850 GBP
10p ordinaryPurchase

461,233

5.5900 GBP
10p ordinarySale

70

5.5900 GBP
10p ordinarySale

651

5.5902 GBP
10p ordinarySale

5,760

5.5893 GBP

(b) Cash-settled derivative transactions

Class of

ProductNature of dealing

Number of

Price per

relevant

description

reference

unit

security

securities

 

10p ordinary

SWAPShort

655

5.5899 GBP

10p ordinary

CFDShort

526,484

5.5906 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:

5 Aug 2021

Contact name:Large Holdings Regulatory Operations
Telephone number:

020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210805005581/en/

Copyright Business Wire 2021

Date   Source Headline
29th Sep 20178:52 amRNSHolding(s) in Company
7th Sep 201712:09 pmRNSHolding(s) in Company
21st Aug 20177:00 amRNSST. MODWEN COMPLETES £470M NINE ELMS SQUARE SALE
18th Aug 20178:30 amRNSBURTON GATEWAY LETTING SUPPORTS LOGISTICS FOCUS
11th Aug 20178:58 amRNSHolding(s) in Company
1st Aug 20172:34 pmRNSTotal Voting Rights
27th Jul 20174:43 pmRNSDirector/PDMR Shareholding
10th Jul 20172:59 pmRNSAdditional Listing
7th Jul 20175:33 pmRNSDirector/PDMR Shareholding
4th Jul 201711:13 amRNSDirector/PDMR Shareholding
4th Jul 20177:00 amRNSHalf Year Results for the period ended 31 May 2017
29th Jun 201710:18 amRNSHolding(s) in Company
21st Jun 201710:48 amRNSCONTRACTS EXCHANGED ON NINE ELMS SQUARE FOR £470M
14th Jun 20179:31 amRNSNotice of Results
7th Jun 20177:00 amRNSTrading Update / Capital Markets Day
30th May 20177:00 amRNSDirector Declaration
30th May 20177:00 amRNSDirectorate Change
31st Mar 20173:16 pmRNSHolding(s) in Company
29th Mar 20173:30 pmRNSResult of AGM
28th Mar 20179:25 amRNSHolding(s) in Company
23rd Mar 20174:21 pmRNSHolding(s) in Company
22nd Mar 20173:55 pmRNSWithdrawal of AGM Resolution
20th Mar 20174:16 pmRNSHolding(s) in Company
16th Mar 20174:32 pmRNSHolding(s) in Company
15th Mar 20179:52 amRNSRE PRESS SPECULATION / NCGM SALE PROCESS UPDATE
14th Mar 20172:31 pmRNSPASSING OF GROUP CONSTRUCTION DIRECTOR
1st Mar 20174:27 pmRNSHolding(s) in Company
24th Feb 20173:25 pmRNSAnnual Financial Report
20th Feb 20172:22 pmRNSHolding(s) in Company
7th Feb 20177:00 amRNSAnnual Results for the Year Ended 30 November 2016
3rd Feb 20174:05 pmRNSHolding(s) in Company
5th Jan 201710:35 amRNSNotice of Results
12th Dec 20164:56 pmRNSHolding(s) in Company
9th Dec 201611:00 amRNSDirector Declaration
6th Dec 20164:14 pmRNSHolding(s) in Company
5th Dec 20167:00 amRNSTRADING UPDATE
16th Nov 20164:39 pmRNSHolding(s) in Company
2nd Nov 20165:01 pmRNSDirector/PDMR Shareholding
1st Nov 20169:00 amRNSDirectorate Change
19th Oct 20167:46 amRNSDirector Declaration
17th Oct 20169:33 amRNSDirector/PDMR Shareholding
7th Oct 20164:35 pmRNSHolding(s) in Company
4th Oct 20163:53 pmRNSDirector/PDMR Shareholding
14th Sep 20165:03 pmRNSHolding(s) in Company
1st Sep 201610:10 amRNSDirector/PDMR Shareholding
15th Aug 20164:39 pmRNSDirector/PDMR Shareholding
1st Aug 20163:16 pmRNSDividend Declaration
26th Jul 20162:28 pmRNSDirector/PDMR Shareholding
18th Jul 201611:58 amRNSDirector/PDMR Shareholding
13th Jul 20167:10 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.